| Code | 1791E | ||||||||||
| MA number | 34/0224/19-S | ||||||||||
| Product Form: | sol iru 6x250 mg/5 ml (striek.skl.naplnená+6x ihla) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | STADA Arzneimittel AG, Germany | ||||||||||
| Therapeutic Class: | 34 - ANTIHORMONA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 48 | ||||||||||
| Container: | glass pre-filled syringe | ||||||||||
| Route of admin.: | Intramuscular use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 16.07.2019 |
| Pediatric warnings: | Yes |
| SPC: |
SPC_Fulvestrant STADA 250 mg sol iru_09_2023.pdf
|
| PIL: |
PIL_Fulvestrant STADA 250 mg sol iru_09_2023.pdf
|
| Safety feature | Yes |
| Data update: | 06.02.2024 |
